CIK 0001087294 · Non-accelerated filer<br>Smaller reporting company
CUMBERLAND PHARMACEUTICALS INC
Sign in to watch- Ticker
- CPIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- TN
- Entity type
- operating
- EIN
- 621765329
- Phone
- 615-255-0068
- Business address
- 1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
- 4 Grant or award Director acquired 5,800 shares (grant or award)
- 4 Grant or award Director acquired 1,800 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Chairman and CEO gave up 5,845 shares (to pay taxes)
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 10-K Report Annual Report
- 8-K Event Results of operations
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Other events
- 4 Other acquisition Director acquired 66 shares (code L)
- 4 Other acquisition Director acquired 270 shares (code L)
- 4 Other acquisition Chairman and CEO acquired 270 shares (code L)
- 4 Other acquisition Director acquired 1,916 shares (code L)
- 4 Other acquisition Director acquired 75 shares (code L)
Page 2 of 52 · 1,039 filings